首页 > 最新文献

中华心血管病杂志最新文献

英文 中文
[Correlation between serum growth differentiation factor 11 level and severity of coronary artery disease in patients with acute myocardial infarction]. [急性心肌梗死患者血清生长分化因子 11 水平与冠状动脉疾病严重程度的相关性]。
Q3 Medicine Pub Date : 2024-03-24 DOI: 10.3760/cma.j.cn112148-20230715-00005
B D Xu, K Chen, Y H Liu, W T Su, T Ye, G Y Wu, G J Zong

Objective: To investigate the correlation between serum growth differentiation factor 11 (GDF11) level and coronary artery lesions in patients with ST-segment elevation myocardial infarction (STEMI), and the predictive efficacy of nomogram risk prediction model based on GDF11 combined with traditional risk factors on the occurrence of STEMI. Methods: This study was a retrospective cross-sectional study. Patients hospitalized in the Department of Cardiology of the 904th Hospital of Joint Logistic Support Force of People's Liberation Army of China from 2016 to 2018 were selected and divided into control group and STEMI group. The demographic data, blood lipid level, laboratory indicators of blood and GDF11 level were collected. Logistic regression analysis screened out independent correlated factors for the occurrence of STEMI. Spearman correlation analysis clarified the correlation of each indicator with the SYNTAX or Gensini scores. A nomogram risk prediction model for the risk of STEMI occurrence and the receiver operating characteristic curve was used to compare the prediction efficiency of each model. Results: A total of 367 patients were enrolled, divided into control group (n=172) and STEMI group (n=195), age (66.5±11.8), male 222 (60.49%). The serum GDF11 level of STEMI group was significantly lower than that of the control group (36.20 (16.60, 70.75) μg/L vs. 85.00 (53.93, 117.10) μg/L, P<0.001). The results of multivariate logistic regression analysis showed serum GDF11(OR=0.98, 95%CI: 0.97-0.99) and traditional independent risk factors such as smoking, diabetes, C-reactive protein, homocysteine, lipoprotein (a) and apolipoprotein A1/B were independent correlate factors for the occurrence of STEMI (P<0.05). Spearman correlation analysis showed that serum GDF11 was negatively correlated with SYNTAX score and Gensini score (P<0.05). The nomogram model constructed by serum GDF11 combined with traditional independent risk factors (AUC=0.85, 95%CI: 0.81-0.89) had better predictive value for the occurrence of STEMI than the traditional nomogram model constructed by independent risk factors(AUC=0.80, 95%CI:0.75-0.84) or serum GDF11 (AUC=0.76, 95%CI: 0.72-0.81), all P<0.01. Conclusions: Serum GDF11 is an independent correlate factor in the occurrence of STEMI and is negatively correlated with the severity of coronary artery lesions in patients with STEMI. The nomogram model constructed based on GDF11 combined with traditional risk factors can be a good predictor for the occurrence of STEMI.

目的研究ST段抬高型心肌梗死(STEMI)患者血清生长分化因子11(GDF11)水平与冠状动脉病变的相关性,以及基于GDF11的提名图风险预测模型结合传统风险因素对STEMI发生的预测效果。研究方法本研究为回顾性横断面研究。选取2016年至2018年在中国人民解放军联合后勤保障部队第904医院心内科住院的患者,分为对照组和STEMI组。收集其人口统计学资料、血脂水平、血液实验室指标及GDF11水平。逻辑回归分析筛选出 STEMI 发生的独立相关因素。斯皮尔曼相关分析明确了各指标与 SYNTAX 或 Gensini 评分的相关性。采用STEMI发生风险的提名图风险预测模型和接收者操作特征曲线来比较各模型的预测效率。结果共纳入 367 例患者,分为对照组(172 例)和 STEMI 组(195 例),年龄(66.5±11.8)岁,男性 222 例(60.49%)。STEMI组血清GDF11水平明显低于对照组(36.20 (16.60, 70.75) μg/L vs. 85.00 (53.93, 117.10) μg/L,POR=0.98,95%CI: 0.97-0.99),吸烟、糖尿病、C反应蛋白、同型半胱氨酸、脂蛋白(a)、载脂蛋白A1/B等传统独立危险因素是STEMI发生的独立相关因素(PPCI: 0.与传统的由独立危险因素构建的提名图模型(AUC=0.80,95%CI:0.75-0.84)或血清 GDF11(AUC=0.76,95%CI:0.72-0.81)相比,所有 PConclusions 对 STEMI 发生的预测价值均更高:血清 GDF11 是 STEMI 发生的独立相关因素,与 STEMI 患者冠状动脉病变的严重程度呈负相关。基于 GDF11 和传统危险因素构建的提名图模型可以很好地预测 STEMI 的发生。
{"title":"[Correlation between serum growth differentiation factor 11 level and severity of coronary artery disease in patients with acute myocardial infarction].","authors":"B D Xu, K Chen, Y H Liu, W T Su, T Ye, G Y Wu, G J Zong","doi":"10.3760/cma.j.cn112148-20230715-00005","DOIUrl":"10.3760/cma.j.cn112148-20230715-00005","url":null,"abstract":"<p><p><b>Objective:</b> To investigate the correlation between serum growth differentiation factor 11 (GDF11) level and coronary artery lesions in patients with ST-segment elevation myocardial infarction (STEMI), and the predictive efficacy of nomogram risk prediction model based on GDF11 combined with traditional risk factors on the occurrence of STEMI. <b>Methods:</b> This study was a retrospective cross-sectional study. Patients hospitalized in the Department of Cardiology of the 904th Hospital of Joint Logistic Support Force of People's Liberation Army of China from 2016 to 2018 were selected and divided into control group and STEMI group. The demographic data, blood lipid level, laboratory indicators of blood and GDF11 level were collected. Logistic regression analysis screened out independent correlated factors for the occurrence of STEMI. Spearman correlation analysis clarified the correlation of each indicator with the SYNTAX or Gensini scores. A nomogram risk prediction model for the risk of STEMI occurrence and the receiver operating characteristic curve was used to compare the prediction efficiency of each model. <b>Results:</b> A total of 367 patients were enrolled, divided into control group (<i>n</i>=172) and STEMI group (<i>n</i>=195), age (66.5±11.8), male 222 (60.49%). The serum GDF11 level of STEMI group was significantly lower than that of the control group (36.20 (16.60, 70.75) μg/L vs. 85.00 (53.93, 117.10) μg/L, <i>P</i><0.001). The results of multivariate logistic regression analysis showed serum GDF11(<i>OR=</i>0.98, 95%<i>CI</i>: 0.97-0.99) and traditional independent risk factors such as smoking, diabetes, C-reactive protein, homocysteine, lipoprotein (a) and apolipoprotein A1/B were independent correlate factors for the occurrence of STEMI (<i>P</i><0.05). Spearman correlation analysis showed that serum GDF11 was negatively correlated with SYNTAX score and Gensini score (<i>P</i><0.05). The nomogram model constructed by serum GDF11 combined with traditional independent risk factors (AUC=0.85, 95%<i>CI</i>: 0.81-0.89) had better predictive value for the occurrence of STEMI than the traditional nomogram model constructed by independent risk factors(AUC=0.80, 95%<i>CI</i>:0.75-0.84) or serum GDF11 (AUC=0.76, 95%<i>CI</i>: 0.72-0.81), all <i>P</i><0.01. <b>Conclusions:</b> Serum GDF11 is an independent correlate factor in the occurrence of STEMI and is negatively correlated with the severity of coronary artery lesions in patients with STEMI. The nomogram model constructed based on GDF11 combined with traditional risk factors can be a good predictor for the occurrence of STEMI.</p>","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"52 3","pages":"286-292"},"PeriodicalIF":0.0,"publicationDate":"2024-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140185941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Application of machine learning in risk assessment for acute coronary syndrome]. [机器学习在急性冠状动脉综合征风险评估中的应用]。
Q3 Medicine Pub Date : 2024-03-24 DOI: 10.3760/cma.j.cn112148-20231024-00375
C X Zhao, F Y Zhong, J X Dong, H Ge, J Bu
{"title":"[Application of machine learning in risk assessment for acute coronary syndrome].","authors":"C X Zhao, F Y Zhong, J X Dong, H Ge, J Bu","doi":"10.3760/cma.j.cn112148-20231024-00375","DOIUrl":"10.3760/cma.j.cn112148-20231024-00375","url":null,"abstract":"","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"52 3","pages":"311-315"},"PeriodicalIF":0.0,"publicationDate":"2024-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140185938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Chinese guidelines for the diagnosis and treatment of heart failure 2024]. [中国心力衰竭诊治指南 2024》。]
Q3 Medicine Pub Date : 2024-03-24 DOI: 10.3760/cma.j.cn112148-20231101-00405
{"title":"[Chinese guidelines for the diagnosis and treatment of heart failure 2024].","authors":"","doi":"10.3760/cma.j.cn112148-20231101-00405","DOIUrl":"10.3760/cma.j.cn112148-20231101-00405","url":null,"abstract":"","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"52 3","pages":"235-275"},"PeriodicalIF":0.0,"publicationDate":"2024-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140185939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Keeping pace with the times, enhancing standardized diagnosis and treatment capabilities for heart failure]. [与时俱进,提升心力衰竭规范化诊疗能力]。
Q3 Medicine Pub Date : 2024-03-24 DOI: 10.3760/cma.j.cn112148-20240122-00054
D L Xu, Y L Han, S Y Zhang
{"title":"[Keeping pace with the times, enhancing standardized diagnosis and treatment capabilities for heart failure].","authors":"D L Xu, Y L Han, S Y Zhang","doi":"10.3760/cma.j.cn112148-20240122-00054","DOIUrl":"10.3760/cma.j.cn112148-20240122-00054","url":null,"abstract":"","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"52 3","pages":"231-234"},"PeriodicalIF":0.0,"publicationDate":"2024-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140185944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Feasibility and safety study of distal radial artery approach in emergency PCI of elderly STEMI patients]. [桡动脉远端入路在 STEMI 老年患者急诊 PCI 中的可行性和安全性研究]。
Q3 Medicine Pub Date : 2024-03-24 DOI: 10.3760/cma.j.cn112148-20230831-00119
H Wang, N Yang, Y W Liu, Y M Li

Objective: To investigate the feasibility and safety of distal radial artery approach in emergency percutaneous coronary intervention(PCI) of elderly ST-segment elevation myocardial infarction(STEMI) patients. Methods: This study is a cross-sectional study. Elderly patients with acute myocardial infarction who received emergency PCI at the Third Central Hospital of Tianjin from January 2020 to December 2022 were selected. They were divided into the distal radial artery group and the classic radial artery group based on the puncture location. The success rate, puncture time, surgical success rate, and surgical time of the two groups were observed; The incidence of complications in patients, including radial artery occlusion rate, radial artery spasm rate, local hematoma rate, aneurysm incidence rate were recorded. Results: There were 70 cases in the distal radial artery group, including 33 males (47.1%), aged (65.6±6.7) years old; There were 70 cases in the classic radial artery group, including 35 males (50.0%), aged (66.4±6.9) years old. There was no statistically significant difference in puncture success rate, puncture time, surgical success rate, and surgical time between the distal radial artery group and the classical radial artery group (P>0.05). The incidence of radial artery occlusion in the distal radial artery group was significantly lower than that in the classical radial artery group (1.4% vs. 8.6%, P=0.024). The postoperative compression time in the distal radial artery group was significantly shorter than that in the classical radial artery group ((291.6±10.5) min vs. (343.5±9.8) min, P=0.047). There was no statistically significant difference in the incidence of radial artery spasm, local hematoma, and aneurysm between the two groups (P>0.05). Conclusions: The distal radial artery approach has a lower radial artery occlusion rate, shorter compression time, and better safety. It can be used as a new approach for emergency PCI in elderly patients with STEMI for clinical application.

目的研究桡动脉远端入路在老年 ST 段抬高型心肌梗死(STEMI)患者急诊经皮冠状动脉介入治疗(PCI)中的可行性和安全性。研究方法本研究为横断面研究。选取2020年1月至2022年12月在天津市第三中心医院接受急诊PCI治疗的老年急性心肌梗死患者。根据穿刺位置分为桡动脉远端组和经典桡动脉组。观察两组的成功率、穿刺时间、手术成功率、手术时间;记录患者并发症的发生率,包括桡动脉闭塞率、桡动脉痉挛率、局部血肿率、动脉瘤发生率。结果远端桡动脉组70例,其中男性33例(47.1%),年龄(65.6±6.7)岁;经典桡动脉组70例,其中男性35例(50.0%),年龄(66.4±6.9)岁。桡动脉远端组与经典桡动脉组在穿刺成功率、穿刺时间、手术成功率、手术时间等方面差异无统计学意义(P>0.05)。桡动脉远端组的桡动脉闭塞发生率明显低于传统桡动脉组(1.4% 对 8.6%,P=0.024)。桡动脉远端组的术后压迫时间明显短于传统桡动脉组((291.6±10.5)分钟对(343.5±9.8)分钟,P=0.047)。两组桡动脉痉挛、局部血肿和动脉瘤的发生率差异无统计学意义(P>0.05)。结论:桡动脉远端入路具有更低的桡动脉闭塞率、更短的压迫时间和更好的安全性。可作为 STEMI 老年患者急诊 PCI 的新方法应用于临床。
{"title":"[Feasibility and safety study of distal radial artery approach in emergency PCI of elderly STEMI patients].","authors":"H Wang, N Yang, Y W Liu, Y M Li","doi":"10.3760/cma.j.cn112148-20230831-00119","DOIUrl":"10.3760/cma.j.cn112148-20230831-00119","url":null,"abstract":"<p><p><b>Objective:</b> To investigate the feasibility and safety of distal radial artery approach in emergency percutaneous coronary intervention(PCI) of elderly ST-segment elevation myocardial infarction(STEMI) patients. <b>Methods:</b> This study is a cross-sectional study. Elderly patients with acute myocardial infarction who received emergency PCI at the Third Central Hospital of Tianjin from January 2020 to December 2022 were selected. They were divided into the distal radial artery group and the classic radial artery group based on the puncture location. The success rate, puncture time, surgical success rate, and surgical time of the two groups were observed; The incidence of complications in patients, including radial artery occlusion rate, radial artery spasm rate, local hematoma rate, aneurysm incidence rate were recorded. <b>Results:</b> There were 70 cases in the distal radial artery group, including 33 males (47.1%), aged (65.6±6.7) years old; There were 70 cases in the classic radial artery group, including 35 males (50.0%), aged (66.4±6.9) years old. There was no statistically significant difference in puncture success rate, puncture time, surgical success rate, and surgical time between the distal radial artery group and the classical radial artery group (<i>P</i>>0.05). The incidence of radial artery occlusion in the distal radial artery group was significantly lower than that in the classical radial artery group (1.4% vs. 8.6%, <i>P</i>=0.024). The postoperative compression time in the distal radial artery group was significantly shorter than that in the classical radial artery group ((291.6±10.5) min vs. (343.5±9.8) min, <i>P</i>=0.047). There was no statistically significant difference in the incidence of radial artery spasm, local hematoma, and aneurysm between the two groups (<i>P</i>>0.05). <b>Conclusions:</b> The distal radial artery approach has a lower radial artery occlusion rate, shorter compression time, and better safety. It can be used as a new approach for emergency PCI in elderly patients with STEMI for clinical application.</p>","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"52 3","pages":"276-280"},"PeriodicalIF":0.0,"publicationDate":"2024-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140185942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Clinical research progress in detecting unrecognized myocardial infarction using cardiac magnetic resonance imaging]. [利用心脏磁共振成像检测未识别心肌梗死的临床研究进展]。
Q3 Medicine Pub Date : 2024-03-24 DOI: 10.3760/cma.j.cn112148-20231028-00388
W Zheng, X Huang, X D Zhao, S P Nie
{"title":"[Clinical research progress in detecting unrecognized myocardial infarction using cardiac magnetic resonance imaging].","authors":"W Zheng, X Huang, X D Zhao, S P Nie","doi":"10.3760/cma.j.cn112148-20231028-00388","DOIUrl":"10.3760/cma.j.cn112148-20231028-00388","url":null,"abstract":"","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"52 3","pages":"300-303"},"PeriodicalIF":0.0,"publicationDate":"2024-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140185940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Regulatory mechanisms and assessment of coronary artery calcification: a review]. [冠状动脉钙化的调节机制和评估:综述]。
Q3 Medicine Pub Date : 2024-03-24 DOI: 10.3760/cma.j.cn112148-20231010-00291
X N Chen, X X Jin, S Cui, D M Liu
{"title":"[Regulatory mechanisms and assessment of coronary artery calcification: a review].","authors":"X N Chen, X X Jin, S Cui, D M Liu","doi":"10.3760/cma.j.cn112148-20231010-00291","DOIUrl":"10.3760/cma.j.cn112148-20231010-00291","url":null,"abstract":"","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"52 3","pages":"303-310"},"PeriodicalIF":0.0,"publicationDate":"2024-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140185946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The diagnostic value of genetic testing in familial hypercholesterolemia in patients with premature myocardial infarction]. [早发心肌梗死患者家族性高胆固醇血症基因检测的诊断价值]。
Q3 Medicine Pub Date : 2024-03-24 DOI: 10.3760/cma.j.cn112148-20231011-00305
Y X Cui, J X Song, Z Y Li, S F Li, C F Liu, H Chen

Objective: To evaluate the diagnostic value of gene testing in familial hypercholesterolemia (FH) in patients with premature myocardial infarction(PMI). Methods: This study was a single center cross-sectional study. A retrospective analysis was made on PMI patients who visited the People's Hospital of Peking University from May 1, 2015 to March 31, 2017. Clinical data of patients was collected and gene testing of FH related genes low density lipoprotein receptor (LDLR), proprotein convertase subtilisin/kexin type 9 (PCSK9), apolipoprotein B(APOB) and low density lipoprotein receptor adaptor protein 1(LDLRAP1) was carried out. Clinical diagnosis of FH patients was performed using Simon Broome criteria, DLCN criteria, and FH Chinese expert consensus. Results: There were 188 males (83.6%) among 225 PMI patients, and the age of the first myocardial infarction was (46.6±7.2) years old. Ten patients carried FH pathogenic or possibly pathogenic mutations (4.4%). Compared with Simon Broome standard, DLCN standard and FH Chinese expert consensus, gene testing increased the diagnostic rate of FH by 53.3%, 33.3% and 42.1% respectively. Conclusion: Gene testing is helpful to improve the diagnosis of FH, and it is important to start the standard treatment of FH as early as possible in patients with premature myocardial infarction.

目的评估早发性心肌梗死(PMI)患者家族性高胆固醇血症(FH)基因检测的诊断价值。研究方法本研究为单中心横断面研究。对2015年5月1日至2017年3月31日在北京大学人民医院就诊的PMI患者进行回顾性分析。研究人员收集了患者的临床资料,并对FH相关基因低密度脂蛋白受体(LDLR)、9型丙蛋白转换酶枯草酶/kexin(PCSK9)、载脂蛋白B(APOB)和低密度脂蛋白受体适配蛋白1(LDLRAP1)进行了基因检测。采用西蒙-布鲁姆标准、DLCN标准和FH中国专家共识对FH患者进行临床诊断。结果225例PMI患者中有188名男性(83.6%),首次心肌梗死年龄为(46.6±7.2)岁。10名患者携带FH致病或可能致病突变(4.4%)。与西蒙-布鲁姆标准、DLCN标准和FH中国专家共识相比,基因检测分别提高了53.3%、33.3%和42.1%的FH诊断率。结论基因检测有助于提高FH的诊断率,对早发心肌梗死患者尽早开始FH的标准治疗非常重要。
{"title":"[The diagnostic value of genetic testing in familial hypercholesterolemia in patients with premature myocardial infarction].","authors":"Y X Cui, J X Song, Z Y Li, S F Li, C F Liu, H Chen","doi":"10.3760/cma.j.cn112148-20231011-00305","DOIUrl":"10.3760/cma.j.cn112148-20231011-00305","url":null,"abstract":"<p><p><b>Objective:</b> To evaluate the diagnostic value of gene testing in familial hypercholesterolemia (FH) in patients with premature myocardial infarction(PMI). <b>Methods:</b> This study was a single center cross-sectional study. A retrospective analysis was made on PMI patients who visited the People's Hospital of Peking University from May 1, 2015 to March 31, 2017. Clinical data of patients was collected and gene testing of FH related genes low density lipoprotein receptor (LDLR), proprotein convertase subtilisin/kexin type 9 (PCSK9), apolipoprotein B(APOB) and low density lipoprotein receptor adaptor protein 1(LDLRAP1) was carried out. Clinical diagnosis of FH patients was performed using Simon Broome criteria, DLCN criteria, and FH Chinese expert consensus. <b>Results:</b> There were 188 males (83.6%) among 225 PMI patients, and the age of the first myocardial infarction was (46.6±7.2) years old. Ten patients carried FH pathogenic or possibly pathogenic mutations (4.4%). Compared with Simon Broome standard, DLCN standard and FH Chinese expert consensus, gene testing increased the diagnostic rate of FH by 53.3%, 33.3% and 42.1% respectively. <b>Conclusion:</b> Gene testing is helpful to improve the diagnosis of FH, and it is important to start the standard treatment of FH as early as possible in patients with premature myocardial infarction.</p>","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"52 3","pages":"281-285"},"PeriodicalIF":0.0,"publicationDate":"2024-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140185948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Median arcuate ligament compression syndrome with chest pain as the first symptom: a case report]. [以胸痛为首发症状的正中弓状韧带压迫综合征:病例报告]。
Q3 Medicine Pub Date : 2024-03-24 DOI: 10.3760/cma.j.cn112148-20230802-00046
Z W Shi, B Wang, M Shen, S Q Yue, Y He, Q Q Wang, H Xu, D S Zhong, H M Fu, F L Zhang, X Y Li, J Yu
{"title":"[Median arcuate ligament compression syndrome with chest pain as the first symptom: a case report].","authors":"Z W Shi, B Wang, M Shen, S Q Yue, Y He, Q Q Wang, H Xu, D S Zhong, H M Fu, F L Zhang, X Y Li, J Yu","doi":"10.3760/cma.j.cn112148-20230802-00046","DOIUrl":"10.3760/cma.j.cn112148-20230802-00046","url":null,"abstract":"","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"52 3","pages":"293-294"},"PeriodicalIF":0.0,"publicationDate":"2024-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140185945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Reperfusion strategies for STEMI patients: recent advances in comparative study of pharmaco-invasive strategy and primary PCI]. [STEMI 患者的再灌注策略:药物介入策略和初级 PCI 比较研究的最新进展]。
Q3 Medicine Pub Date : 2024-03-24 DOI: 10.3760/cma.j.cn112148-20231130-00471
Z W Zhang, C Y Wang, B He
{"title":"[Reperfusion strategies for STEMI patients: recent advances in comparative study of pharmaco-invasive strategy and primary PCI].","authors":"Z W Zhang, C Y Wang, B He","doi":"10.3760/cma.j.cn112148-20231130-00471","DOIUrl":"10.3760/cma.j.cn112148-20231130-00471","url":null,"abstract":"","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"52 3","pages":"295-299"},"PeriodicalIF":0.0,"publicationDate":"2024-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140185947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中华心血管病杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1